• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Sohm Inc (OP: SHMN )

    0.0011 UNCHANGED
    Streaming Delayed Price Updated: 1:09 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,003,044
    Open 0.0011
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.0011
    Today's Range 0.0010 - 0.0011
    52wk Range 0.0008 - 0.0022
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    SOHM, Inc. Announce Dr. David Zarling Onboard as Senior Product Development Advisor
    Via ACCESSWIRE
    SOHM, Inc. Continues to Build its IP Portfolio in the Gene Editing and Cell Engineering Space
    Via ACCESSWIRE

    Performance

    YTD
    -31.25%
    -31.25%
    1 Month
    -8.33%
    -8.33%
    3 Month
    +10.00%
    +10.00%
    6 Month
    -8.33%
    -8.33%
    1 Year
    -8.33%
    -8.33%

    More News

    Read More
    SOHM, Inc. has Received ABBIE Technology Kits' Pre-Launch Pre-Orders
    Via ACCESSWIRE
    SOHM, Inc., Announce Dr. Tetsuya Kawamura Ph. D. Joined as a Cell Engineer and Biochemist
    Via ACCESSWIRE
    SOHM, Inc. has signed the Manufacturing and Supply of Skincare Topical Products with New Export Customers
    Via ACCESSWIRE
    SOHM, Inc., Announce a New Collaboration and Joins Forces with Stanford University
    Via ACCESSWIRE
    Rheumatoid Arthritis Patients Face Heightened Risk of Depression, Study Finds
    Via Investor Brand Network
    Why Prescription Drugs Can Be Costly
    Via Investor Brand Network
    SOHM, Inc. Announces its ABBIE Genome Editing Technology Successfully Engineered a T-cell immunotherapy from a Healthy Human Donor
    Via ACCESSWIRE
    BioMedNewsBreaks — SOHM, Inc. (SHMN) Continues to Advance Groundbreaking Technology
    Via Investor Brand Network
    InvestorNewsBreaks – SOHM, Inc. (SHMN), Coastar Therapeutics Collaborate to Advance Field of Genome Editing
    Via Investor Brand Network
    FDA Grants Florida Permission to Import More Affordable Medicines from Canada
    Via Investor Brand Network
    Exposures Product Safety
    Small Study Shows Existing Drug Could Reduce Opioid Administration After Surgery
    Via Investor Brand Network
    New Compound Promises Greater Efficacy Against Pain, Has No Side Effects
    Via Investor Brand Network
    BioMedNewsBreaks– SOHM Inc. (SHMN) Announces Filing of Provisional Patent for ABBIE Smart Gene Editing Technology
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety
    SOHM Files Provisional Patent on ABBIE’s ‘Smart Gene-Editing’ That Uses Latest Enzymes and Guide RNA to Resolve Off-Target Gene-Editing Limitations
    From SOHM, Inc.
    Via GlobeNewswire
    FDA Announces Changes to Safety Labeling Requirements for Opioid Medications
    Via Investor Brand Network
    Exposures Product Safety
    SOHM Inc. (SHMN) Releases New Product Line and Expands Manufacturing Operations in Carlsbad, California
    Via Investor Brand Network
    BioMedNewsBreaks — Why SOHM Inc. (SHMN) Is ‘One to Watch’
    Via Investor Brand Network
    Senate Committee Hears How Drug Shortages Impact Patients
    Via Investor Brand Network
    SOHM Inc.’s (SHMN) New Gene-Editing Technology Holds Potential to Revolutionize the Field of Cardiology, With Superior Capabilities Over Other Gene-Editing Systems
    Via Investor Brand Network
    SOHM Inc. (SHMN) Taps into UACI’s Robust Resources and Specialized Infrastructure for ABBIE Advancement
    Via Investor Brand Network
    BioMedNewsBreaks – SOHM, Inc. (SHMN) Announces 2024 Outlook for Business Units
    Via Investor Brand Network
    SOHM Announces Business Outlook for 2024
    From SOHM, Inc.
    Via GlobeNewswire
    Topical Analgesics Emerge as Important Pain-Management Tools
    Via Investor Brand Network
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.